Flexibility in Phase I Study Timing

Combined Phase I protocols can accelerate access to DDI, QT assessment, food, age, or gender affect, as well as cognitive or dependence data. With earlier access to this information, you have the power to make more informed drug development decisions, and possibly obtain a waiver for certain later-phase studies. We can help you achieve the earliest, most complete understanding of your developmental product.

In this issue of The Altascientist we explain how COMBINED PROTOCOLS can help you, including two illustrative scenarios.

First Name *

Last Name *

Email *

Company Name *

Company Type *

Job Function *

Job Level *

Dive Publication

Field will not be visible to web visitor

By completing this form, you agree to our Terms of Use , Privacy Policy , and your information being shared with our sponsor, Altasciences.*

Flexibility in Phase I Study Timing

GET THE PUBLICATION

Form submitted successfully.

Please verify your mobile number